Holen Sie sich die Stockscreener-App
0.00
100.00%
-70.98
Handel nachbörslich:
70.95
70.95
+
Schlusskurs vom Vortag:
$70.98
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$3.63B
Einnahmen:
$431.90M
Nettoeinkommen (Verlust:
$-5.66M
KGV:
0.00
EPS:
-0.25
Netto-Cashflow:
$5.37M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$71.05
Axonics Inc Stock (AXNX) Company Profile
Firmenname
Axonics Inc
Sektor
Branche
Telefon
949-396-6322
Adresse
26 TECHNOLOGY DRIVE, IRVINE, CA
Vergleichen Sie AXNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXNX
Axonics Inc
|
0.00 | 3.63B | 431.90M | -5.66M | 5.37M | -0.1204 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Axonics Inc Stock (AXNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-07-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-23 | Eingeleitet | CL King | Buy |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-24 | Hochstufung | Needham | Hold → Buy |
| 2022-10-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-10-10 | Herabstufung | Needham | Buy → Hold |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-07-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-28 | Bestätigt | Needham | Buy |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-07 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-11-01 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-10-21 | Eingeleitet | Barclays | Overweight |
| 2019-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2019-09-09 | Bestätigt | Needham | Buy |
| 2019-09-03 | Eingeleitet | Needham | Buy |
| 2019-06-13 | Bestätigt | BofA/Merrill | Buy |
| 2018-11-26 | Eingeleitet | BofA/Merrill | Buy |
| 2018-11-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-11-26 | Eingeleitet | SunTrust | Buy |
| 2018-11-26 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Axonics Inc Aktie (AXNX) Neueste Nachrichten
Boston Scientific stock holds rating after Axonics acquisition - Investing.com
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors - PR Newswire UK
Boston Sci. Completes $3.7B Axonics Buy - Orange County Business Journal
Thibodaux Regional Urology Clinic Recognized as an Axonics® Center of Excellence - Lafourche Gazette
Boston Scientific Stock Set to Gain From Completion of Axonics Deal - MSN
Axonics, Inc. (NASDAQ:AXNX) Stock Holdings Raised by Alpine Associates Management Inc. - MarketBeat
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates - MSN
Boston Scientific Completes $3.7B Acquisition of Axonics - Orange County Business Journal
Boston Scientific Completes Strategic Acquisition of Axonics - Zenopa
LMR Partners LLP Reduces Stock Holdings in Axonics, Inc. (NASDAQ:AXNX) - MarketBeat
Boston Scientific Completes Acquisition of Axonics - Zenopa
Boston Scientific acquires Axonics - Medical Buyer
Boston Scientific Closes Acquisition of Axonics - FinSMEs
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors - The Manila Times
Short Interest in Axonics, Inc. (NASDAQ:AXNX) Grows By 5.4% - MarketBeat
Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus.com
Boston Scientific completes $3.7B purchase of California bowel dysfunction company - Worcester Business Journal
Boston Scientific finalizes $3.7B acquisition of Axonics - Mass Device
Boston Scientific closes $3.7B Axonics deal after lengthy review - MedTech Dive
Boston Sci Closes Acquisition of Medtronic’s Neuromodulation Foe - MD+DI
Boston Scientific Closes $3.7B Deal for Axonics - MPO-mag
Boston Scientific closes acquisition of Axonics, Inc - Med-Tech Innovation
Axonics Modulation Technologies Merges and Delists from Nasdaq - TipRanks
Axonics, Inc. Announces Management Changes - Marketscreener.com
Boston Scientific Completes $3.7B Axonics Acquisition, Expands Urology Portfolio | BSX Stock News - StockTitan
Axonics, Inc. (NASDAQ:AXNX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Axonics stock soars to 52-week high, reaches $70.93 By Investing.com - Investing.com Australia
Axonics stock soars to 52-week high, reaches $70.93 - Investing.com India
Axonics gains after Nasdaq delisting notice for sale to Boston Scientific - MSN
SoniVie Names Axonics' Raymond Cohen as Chairman Following $3.7B Boston Scientific Deal | BSX Stock News - StockTitan
Versor Investments LP Sells 30,587 Shares of Axonics, Inc. (NASDAQ:AXNX) - MarketBeat
Axonics’ Q3 2024: Revenue Growth Amid Challenges - TipRanks
Axonics' (AXNX) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
Axonics: Q3 Earnings Snapshot - Houston Chronicle
Axonics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Axonics Reports Third Quarter 2024 Financial Results - BioSpace
Axonics Inc (AXNX) Q3 2024 Earnings: Revenue Hits $116.2 Million, Surpassing Estimates - GuruFocus.com
Medtronic Says Axonics Misled Jury To Beat Patent Case - Law360
Axonics stock soars to 52-week high, reaches $70.6 - Investing.com
Axonics stock soars to 52-week high, reaches $70.6 By Investing.com - Investing.com UK
Axonics’ Market Growth Strengthens Boston Scientific’s Future (NASDAQ:AXNX) - Seeking Alpha
Boston Scientific Announces Agreement to Acquire Cortex, Inc. - StockTitan
Axonics, Inc. (NASDAQ:AXNX) Shares Sold by Oak Ridge Investments LLC - MarketBeat
Finanzdaten der Axonics Inc-Aktie (AXNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):